Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Transitional Cell × durvalumab × Clear all

Phase

Phase 2 6 Phase 1/2 2 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 29 Lung Neoplasms 9 Small Cell Lung Carcinoma 7 Biliary Tract Neoplasms 7 Carcinoma, Hepatocellular 5 Urinary Bladder Neoplasms 4 Liver Neoplasms 4 Carcinoma 4 Small Cell Lung Carcinoma Extensive Disease 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Gallbladder Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Urothelial Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pancoast Syndrome 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Small Cell Lung Carcinoma NSCLC 1 Non Small Cell Lung Cancer NSCLC 1 Non - Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1

Interventions

Gemcitabine 10 Mitomycin 9 Cisplatin 8 Carboplatin 7 pembrolizumab 5 Docetaxel 4 toripalimab 3 avelumab 3 atezolizumab 3 Paclitaxel 3 sacituzumab govitecan 2 Taxes 2 Specimen Handling 2 Platinum 2 Magnetic Resonance Spectroscopy 2 Injections 2 1,2-diaminocyclohexaneplatinum II citrate 2 vinflunine 1 valrubicin 1 tislelizumab 1 lenvatinib 1 eribulin 1 epacadostat 1 durvalumab 1 dodecyl maltoside 1 disitamab vedotin 1 Vitamin B 12 1 Standard of Care 1 Ramucirumab 1 Polysorbates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04637594 2025-01-15

IMAGINE

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡